CARGO Therapeutics’ Post

Congratulations to Stanford University School of Medicine investigators on the first peer-reviewed publication of their Phase 1 clinical study evaluating our lead candidate CD22 CAR T-cell therapy, firi-cel, in the The Lancet! These impactful findings continue to demonstrate the curative potential of firi-cel and support the study design of our currently enrolling Phase 2 program. Learn more: https://lnkd.in/dH_QQNmK #CART #celltherapy

The CARGO team is growing! We’re #hiring a Director of Biostatistics to join our team. Join us as we advance potentially transformative CAR T therapies to impact patients worldwide. Learn more about the role here: https://lnkd.in/e3V6DPia #careers #biotechnology

CARGO Therapeutics is #hiring a Senior Scientist in Analytical Development. In this role, you’ll contribute to the development of cell-based and molecular assays. Join us as we work to develop potentially curative CAR T therapies. Read more about the role here: https://lnkd.in/eK9YrtuA #careers #biotechnology

The CARGO team is #hiring a Clinical Project Manager. In this role, you’ll support early-phase clinical research trials. Your work will directly support CARGO’s mission to outsmart cancer through the development of next generation CAR T-cell therapies. Come join us! https://lnkd.in/ecdiJQhN #biotechjobs #celltherapy

We're thrilled to be featured in the 2024 New Era in Life Sciences Report published in Newsweek and Investment Reports, which highlights recent innovations and advancements in the field, including CARGO’s work to develop CAR T-cell therapies designed to address unmet patient needs: https://lnkd.in/diZsNp3i #celltherapy #CART

We’re pleased to announce the appointment of Jane Pritchett Henderson to our Board of Directors, adding strategic finance and broad biotech operating experience as we continue to execute our potentially pivotal Phase 2, FIRCE-1 clinical study, while advancing our CAR T pipeline. Learn more: https://lnkd.in/eQWfU3yc #CART #celltherapy

Join CARGO’s President and CEO Gina Chapman for a fireside chat at the Jefferies Global Healthcare Conference in New York City, on June 5 at 11:30 a.m. EST, where she will share our latest company highlights. Learn more here: https://lnkd.in/exiE5HCA #CART #JefferiesHealthcare #celltherapy

At CARGO, we are tenacious in the relentless pursuit of our mission to develop potentially curative treatments for more patients. We’re currently hiring an Associate Director, Statistical Programming, who will play a critical role in advancing our clinical development programs. Learn more: https://lnkd.in/e5UWD84e  #biotechjobs #careers #CART

Today we announced a $110 million private placement equity financing with participation from new and existing leading healthcare investors. This financing will support BLA preparation for our potentially pivotal Phase 2 study FIRCE-1 of firi-cel and IND-enabling studies for CRG-023, our novel tri-specific CAR T. Learn more: https://lnkd.in/ec5_ydUm #CART #celltherapy #oncology

We’re hiring a Scientist, Discovery, to join our growing team! At CARGO, we are focused on developing next-generation CAR T-cell therapies to outsmart cancer and deliver more cures. In this role, you’ll have the opportunity to make an impact from the start. Learn more: https://lnkd.in/ezFdb7Ds #biotechjobs #CART #celltherapy